These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20133005)

  • 41. Letter to the Editor: Is eliminating METTL1-mediated accumulation of PMN-MDSCs sufficient to prevent hepatocellular carcinoma recurrence after radiofrequency ablation?
    Yang F; Jiang S; Zheng Y
    Hepatology; 2023 Apr; 77(4):E62-E63. PubMed ID: 35753066
    [No Abstract]   [Full Text] [Related]  

  • 42. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.
    Kurokohchi K; Watanabe S; Masaki T; Hosomi N; Funaki T; Arima K; Yoshida S; Nakai S; Murota M; Miyauchi Y; Kuriyama S
    Int J Oncol; 2002 Sep; 21(3):611-5. PubMed ID: 12168107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost.
    Seror O; N'Kontchou G; Tin Tin Htar M; Durand-Zaleski I; Trinchet JC; Sellier N; Beaugrand M
    Gastroenterol Clin Biol; 2006 Nov; 30(11):1265-73. PubMed ID: 17185968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Percutaneous ethanol injection of unresectable medium-to-large-sized hepatomas using a multipronged needle: efficacy and safety.
    Ho CS; Kachura JR; Gallinger S; Grant D; Greig P; McGilvray I; Knox J; Sherman M; Wong F; Wong D
    Cardiovasc Intervent Radiol; 2007; 30(2):241-7. PubMed ID: 17200905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E
    Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic ultrasonography-guided ethanol injection as a treatment for ruptured hepatocellular carcinoma in the left hepatic lobe.
    Nakaji S; Hirata N; Kobayashi M; Shiratori T; Sanagawa M
    Endoscopy; 2015; 47 Suppl 1():E558-60. PubMed ID: 26610083
    [No Abstract]   [Full Text] [Related]  

  • 47. Ablative therapy of malignant liver neoplasm.
    Badruddoja M
    Arch Surg; 2006 Sep; 141(9):947; author reply 947-8. PubMed ID: 16983043
    [No Abstract]   [Full Text] [Related]  

  • 48. [Evaluation of efficacy of liver cancer microwave ablation at 5 years postoperatively].
    Zhao L; Zhuang DM; Hou XW; Wang GF; Zhang HW; Zhuang XX
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):648-650. PubMed ID: 31594085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K; Yoshioka H; Ito S; Fujiwara K
    Hepatology; 1998 Jan; 27(1):67-72. PubMed ID: 9425919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Percutaneous ablation of hepatocellular carcinoma].
    Sitruk V; Seror O; Grando-Lemaire V; Mohand D; N'Kontchou G; Ganne-Carrie N; Beaugrand M; Sellier N; Trinchet JC
    Gastroenterol Clin Biol; 2003 Apr; 27(4):381-90. PubMed ID: 12759677
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for hepatocellular carcinoma in cirrhotic patients: a prospective study.
    Huo TI; Huang YH; Wu JC; Lee PC; Chang FY; Lee SD
    Scand J Gastroenterol; 2003 Jul; 38(7):770-8. PubMed ID: 12889565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma--a long-term follow-up study.
    Tsai WL; Cheng JS; Lai KH; Lin CP; Lo GH; Hsu PI; Yu HC; Lin CK; Chan HH; Chen WC; Chen TA; Li WL; Liang HL
    Aliment Pharmacol Ther; 2008 Aug; 28(3):304-11. PubMed ID: 19086330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiofrequency ablation of hepatocellular carcinoma: Mono or multipolar?
    Cartier V; Boursier J; Lebigot J; Oberti F; Fouchard-Hubert I; Aubé C
    J Gastroenterol Hepatol; 2016 Mar; 31(3):654-60. PubMed ID: 26414644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis.
    Poggi G; Gatti C; Teragni C; Delmonte A; Bernardo G
    Anticancer Res; 2004; 24(4):2419-21. PubMed ID: 15330193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One-month apparent diffusion coefficient correlates with response to radiofrequency ablation of hepatocellular carcinoma.
    Barat M; Fohlen A; Cassinotto C; Jannot AS; Dautry R; Pelage JP; Boudiaf M; Pocard M; Eveno C; Taouli B; Soyer P; Dohan A
    J Magn Reson Imaging; 2017 Jun; 45(6):1648-1658. PubMed ID: 27766709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Percutaneous tumor ablation for hepatocellular carcinoma.
    Gervais DA; Arellano RS
    AJR Am J Roentgenol; 2011 Oct; 197(4):789-94. PubMed ID: 21940565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Focus.
    Shouval D
    J Hepatol; 2012 Oct; 57(4):713-4. PubMed ID: 22824817
    [No Abstract]   [Full Text] [Related]  

  • 59. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transpulmonary radiofrequency ablation of hepatocellular carcinoma contiguous to the heart.
    Iguchi T; Inoue D; Tatsukawa M; Yabushita K; Sakaguchi K; Kanazawa S
    Diagn Interv Imaging; 2015 Nov; 96(11):1207-9. PubMed ID: 26277644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.